Holen Sie sich die Stockscreener-App
6.64
5.90%
0.37
Handel nachbörslich:
6.70
0.06
+0.90%
Schlusskurs vom Vortag:
$6.27
Offen:
$6.31
24-Stunden-Volumen:
741.45K
Relative Volume:
0.83
Marktkapitalisierung:
$562.36M
Einnahmen:
$73.48M
Nettoeinkommen (Verlust:
$-108.30M
KGV:
-2.9511
EPS:
-2.25
Netto-Cashflow:
$-67.17M
1W Leistung:
+13.12%
1M Leistung:
+70.69%
6M Leistung:
+457.98%
1J Leistung:
+240.51%
1-Tages-Spanne:
$6.25
$6.73
1-Wochen-Bereich:
$5.48
$6.73
52-Wochen-Spanne:
$1.12
$7.20
Personalis Inc Stock (PSNL) Company Profile
Firmenname
Personalis Inc
Sektor
Branche
Telefon
650-752-1300
Adresse
6600 DUMBARTON CIRCLE, FREMONT, CA
Vergleichen Sie PSNL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PSNL
Personalis Inc
|
6.64 | 562.36M | 73.48M | -108.30M | -67.17M | -2.25 |
|
TMO
Thermo Fisher Scientific Inc
|
532.02 | 203.50B | 42.37B | 6.14B | 7.78B | 15.95 |
|
DHR
Danaher Corp
|
234.84 | 169.62B | 23.74B | 3.89B | 4.98B | 5.24 |
|
A
Agilent Technologies Inc
|
135.69 | 38.75B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
197.39 | 35.83B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
415.53 | 34.03B | 3.84B | 866.24M | 792.60M | 10.37 |
Personalis Inc Stock (PSNL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-02-06 | Hochstufung | Needham | Hold → Buy |
| 2022-01-07 | Hochstufung | BofA Securities | Neutral → Buy |
| 2021-11-05 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-03 | Herabstufung | Needham | Buy → Hold |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-09-20 | Bestätigt | Needham | Buy |
| 2021-05-06 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-01-28 | Eingeleitet | Truist | Buy |
| 2021-01-04 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-11-12 | Bestätigt | Needham | Buy |
| 2020-11-06 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-10-19 | Eingeleitet | Citigroup | Buy |
| 2020-10-08 | Eingeleitet | BTIG Research | Buy |
| 2020-08-27 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-08-18 | Eingeleitet | Needham | Buy |
| 2019-09-26 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | Eingeleitet | BofA/Merrill | Neutral |
| 2019-07-15 | Eingeleitet | Cowen | Outperform |
| 2019-07-15 | Eingeleitet | Morgan Stanley | Overweight |
| 2019-07-15 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Personalis Inc Aktie (PSNL) Neueste Nachrichten
Personalis, Inc. (NASDAQ:PSNL) Stake Raised by State Street Corp - Defense World
Jane Street Group LLC Increases Stock Position in Personalis, Inc. (NASDAQ:PSNL) - Defense World
Personalis, Inc. (NASDAQ:PSNL) Stock Position Reduced by Stifel Financial Corp - Defense World
Personalis, Inc. Amends Sales Agreement with Piper Sandler & Co. and BTIG - Defense World
The 16% return this week takes Personalis' (NASDAQ:PSNL) shareholders one-year gains to 159% - Yahoo Finance
Grail (NASDAQ:GRAL) & Personalis (NASDAQ:PSNL) Financial Contrast - Defense World
Local vaccine biotech secures $50 million Merck investment - The Business Journals
Personalis price target raised to $8 from $7 at BTIG - Yahoo Finance
Personalis Announces Investment Agreement with Merck in Latest 8-K Filing - Defense World
Personalis stock rallies 25% amid $50M Merck investment - MSN
Personalis shares target increased, buy rating on Merck investment By Investing.com - Investing.com
Personalis' (PSNL) "Buy" Rating Reiterated at Needham & Company LLC - MarketBeat
Personalis (NASDAQ:PSNL) Price Target Raised to $11.00 at HC Wainwright - MarketBeat
Personalis (NASDAQ:PSNL) shareholder returns have been solid, earning 248% in 1 year - Simply Wall St
Personalis (PSNL) Stock Jumps After-Market Following Major Business Moves - Stocks Telegraph
Personalis secures investment from Merck, extends Moderna deal By Investing.com - Investing.com Canada
Personalis, Inc. announced that it expects to receive $49.999997 million in funding from Merck Sharp & Dohme LLC - Marketscreener.com
Personalis Inc share price jumps 50% on deals with Merck and Moderna - Mugglehead
Personalis Secures $50M from Merck, Extends Collaboration with Moderna - HIT Consultant
Personalis Shares Surge After Merck's $50 Million Investment - MarketWatch
Merck Buys $50 Million of Personalis Stock - Marketscreener.com
Personalis Lands $50M Merck Investment, Extends Key Moderna Partnership for Cancer Therapy Platform - StockTitan
Personalis SVP sells $5,779 in stock - Investing.com India
Personalis CFO Aaron Tachibana sells $26,224 in stock By Investing.com - Investing.com Australia
Personalis CFO Aaron Tachibana sells $26,224 in stock - Investing.com India
Personalis SVP sells $5,779 in stock By Investing.com - Investing.com UK
Tempus AI, Inc (TEM) Expands Partnership with Personalis to Advance Ultra-Sensitive MRD Testing for Biopharma - Insider Monkey
Personalis and Tempus Expand Collaboration to Biopharma - sharewise
Personalis, Tempus Expand Partnership to Revolutionize Cancer Detection with Advanced MRD Testing - StockTitan
Personalis, Inc. and Tempus AI, Inc. Expand Collaboration to Biopharma - Marketscreener.com
Jacobs Levy Equity Management Inc. Sells 329,335 Shares of Personalis, Inc. (NASDAQ:PSNL) - MarketBeat
Walleye Capital LLC Buys Shares of 166,788 Personalis, Inc. (NASDAQ:PSNL) - MarketBeat
Gene Panel Market to Surpass USD 11.75 Billion by 2031 | SkyQuest Technology - GlobeNewswire Inc.
Personalis CFO Aaron Tachibana sells $4,953 in stock By Investing.com - Investing.com Australia
Personalis SVP sells $6,416 in stock - Investing.com India
Personalis CFO Aaron Tachibana sells $4,953 in stock - Investing.com India
Personalis SVP sells $6,416 in stock By Investing.com - Investing.com Nigeria
Personalis to Participate at Upcoming Investor Conferences - The Bakersfield Californian
Personalis, Inc. (NASDAQ:PSNL) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny - Simply Wall St
Personalis, Inc. (NASDAQ:PSNL) Shares Sold by GSA Capital Partners LLP - MarketBeat
Personalis Inc. (PSNL) Quarterly 10-Q Report - Quartzy
FY2024 EPS Estimate for Personalis Decreased by Analyst - Defense World
FY2024 EPS Estimates for Personalis Cut by HC Wainwright - MarketBeat
Here's Why We're Not Too Worried About Personalis' (NASDAQ:PSNL) Cash Burn Situation - Yahoo Finance
Personalis, Inc. (NASDAQ:PSNL) Q3 2024 Earnings Call Transcript - Insider Monkey
Finanzdaten der Personalis Inc-Aktie (PSNL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Personalis Inc-Aktie (PSNL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Moore Stephen Michael | SVP and Chief Legal Officer |
Dec 16 '24 |
Sale |
3.82 |
1,513 |
5,780 |
65,875 |
| Tachibana Aaron | CFO AND COO |
Dec 16 '24 |
Sale |
3.82 |
6,865 |
26,224 |
167,098 |
| Tachibana Aaron | CFO AND COO |
Nov 18 '24 |
Sale |
3.79 |
1,307 |
4,954 |
173,963 |
| Moore Stephen Michael | SVP and Chief Legal Officer |
Nov 18 '24 |
Sale |
3.79 |
1,693 |
6,416 |
67,388 |
| Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
Nov 18 '24 |
Sale |
3.79 |
921 |
3,491 |
128,720 |
| Hall Christopher M | PRESIDENT AND CEO |
Nov 01 '24 |
Sale |
5.38 |
26,443 |
142,263 |
178,098 |
| Tempus AI, Inc. | 10% Owner |
Aug 16 '24 |
Buy |
5.07 |
3,500,000 |
17,745,000 |
12,718,800 |
| Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
Jul 30 '24 |
Sale |
2.97 |
524 |
1,556 |
127,227 |
| Tachibana Aaron | CFO AND COO |
Jul 30 '24 |
Sale |
2.97 |
742 |
2,204 |
175,270 |
| Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
Jun 17 '24 |
Sale |
1.29 |
5,055 |
6,521 |
127,751 |
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):